SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Stolt J) "

Sökning: WFRF:(Stolt J)

  • Resultat 1-50 av 59
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Balldin, J, et al. (författare)
  • A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence
  • 2003
  • Ingår i: Alcoholism: Clinical and Experimental Research. - 0145-6008 .- 1530-0277. ; 11
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: In several studies, patients with alcohol dependence treated with the opioid antagonist naltrexone have shown fewer relapses to heavy drinking than those receiving placebo. An interaction between the naltrexone effect and the type of psychological therapy has been observed. Methods: A 6-month, double-blind, placebo-controlled, parallel-group study was performed at 10 different investigation sites. After a placebo run-in period of 1 week, 118 patients were randomized into 4 treatment groups—50 mg of naltrexone daily or placebo in combination with either cognitive behavioral therapy (CBT) or supportive therapy. The CBT was performed over nine sessions according to the manual of Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity). The supportive therapy was defined as "the treatment as usual." Alcohol consumption, craving, carbohydrate-deficient transferrin, medication compliance by tablet count, and adverse clinical events were assessed at all visits. Other liver enzymes and psychiatric symptoms were also determined. Results: Ninety-one (77%) patients completed the study, and 92 (78%) were 80% compliant with the medication regimen. A lower percentage of heavy-drinking days was shown in the naltrexone group (p = 0.045) compared with the placebo group, as was a lower craving score (p = 0.029). These results are supported by the lower levels of liver enzyme activities (p < 0.010 for aspartate aminotransferase, alanine aminotransferase, and γ-glutamyltransferase), but not by the carbohydrate-deficient transferrin levels, in the naltrexone group. The mean time period before the first day of heavy drinking was longer for the group treated with CBT (p = 0.010), especially in combination with naltrexone (p = 0.007). Naltrexone was well tolerated, and no patients discontinued the study due to side effects. Conclusions: This study supports the effect of naltrexone in outpatient treatment of alcohol dependence and suggests that a beneficial interaction effect with CBT can be expected.
  •  
2.
  •  
3.
  • Buker, O., et al. (författare)
  • Metrological support for LNG custody transfer and transport
  • 2016
  • Ingår i: Proceedings of the 17th International Flow Measurement Conference (FLOMEKO 2016).
  • Konferensbidrag (refereegranskat)abstract
    • In the framework of the ongoing EMRP Joint Research Project (JRP) ENG 60 “Metrology for LNG” (2014-2017), co-funded by the European Union, a number of metrological challenges associated with custody transfer and transport of LNG will be faced. The project consists of four technical work packages (WP), whereby the main objective is to reduce the measurement uncertainty of LNG custody transfer by a factor two. The focus in WP1 is the design and development of a traceable mid-scale calibration standard for LNG mass and volume flow. The goal is to provide traceable mass and volume flow calibrations up to 400 m3/h (180000 kg/h). In WP2, the emphasis is on the development and validation of a LNG sampling and composition measurement reference standard, consisting of sampler, vaporizer, gas standards, and gas chromatography (GC), which will be used to  test and calibrate commercially available LNG sampling and composition measurement systems. The priority in WP3 is given to the development and validation of a method for the determination of the methane number, including correlations based on the LNG composition and corrections for traces of nitrogen and higher hydrocarbons. Since physical properties and quantities play an important role in LNG custody transfer, WP4 comprises reference quality density measurements of LNG to validate and improve models for LNG density predictions, the uncertainty evaluation of enthalpy and calorific value calculations and the development of a novel cryogenic sensor for the simultaneous measurement of speed-of-sound and density. The present paper gives an overview of recently achieved objectives within the project and provides an outlook to future activities.
  •  
4.
  •  
5.
  •  
6.
  • Keller, Jan, et al. (författare)
  • Wide-gap (Ag,Cu)(In,Ga)Se2 solar cells with different buffer materials—A path to a better heterojunction
  • 2020
  • Ingår i: Progress in Photovoltaics. - : Wiley. - 1062-7995 .- 1099-159X. ; 28:4, s. 237-250
  • Tidskriftsartikel (refereegranskat)abstract
    • This contribution concerns the effect of the Ag content in wide-gap AgwCu1-wIn1-xGaxSe2 (ACIGS) absorber films and its impact on solar cell performance. First-principles calculations are conducted, predicting trends in absorber band gap energy (Eg) and band structure across the entire compositional range (w and x). It is revealed that a detrimental negative conduction band offset (CBO) with a CdS buffer can be avoided for all possible absorber band gap values (Eg = 1.0–1.8 eV) by adjusting the Ag alloying level. This opens a new path to reduce interface recombination in wide-gap chalcopyrite solar cells. Indeed, corresponding samples show a clear increase in open-circuit voltage (VOC) if a positive CBO is created by sufficient Ag addition. A further extension of the beneficial compositional range (positive CBO at buffer/ACIGS interface) is possible when exchanging CdS with Zn1-ySnyOz, because of its lower electron affinity (χ). Nevertheless, the experimental results strongly suggest that at present, residual interface recombination still limits the performance of solar cells with optimized CBO, which show an efficiency of up to 15.1% for an absorber band gap of Eg = 1.45 eV.
  •  
7.
  • Tobin, N. P., et al. (författare)
  • Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
  • 2015
  • Ingår i: Annals of Oncology. - : Elsevier BV. - 1569-8041 .- 0923-7534. ; 26:1, s. 81-88
  • Tidskriftsartikel (refereegranskat)abstract
    • We and others have recently shown that tumor characteristics are altered throughout tumor progression. These findings emphasize the need for re-examination of tumor characteristics at relapse and have led to recommendations from ESMO and the Swedish Breast Cancer group. Here, we aim to determine whether tumor characteristics and molecular subtypes in breast cancer metastases confer clinically relevant prognostic information for patients. The translational aspect of the Swedish multicenter randomized trial called TEX included 111 patients with at least one biopsy from a morphologically confirmed locoregional or distant breast cancer metastasis diagnosed from December 2002 until June 2007. All patients had detailed clinical information, complete follow-up, and metastasis gene expression information (Affymetrix array GPL10379). We assessed the previously published gene expression modules describing biological processes [proliferation, apoptosis, human epidermal receptor 2 (HER2) and estrogen (ER) signaling, tumor invasion, immune response, and angiogenesis] and pathways (Ras, MAPK, PTEN, AKT-MTOR, PI3KCA, IGF1, Src, Myc, E2F3, and beta-catenin) and the intrinsic subtypes (PAM50). Furthermore, by contrasting genes expressed in the metastases in relation to survival, we derived a poor metastasis survival signature. A significant reduction in post-relapse breast cancer-specific survival was associated with low-ER receptor signaling and apoptosis gene module scores, and high AKT-MTOR, Ras, and beta-catenin module scores. Similarly, intrinsic subtyping of the metastases provided statistically significant post-relapse survival information with the worst survival outcome in the basal-like [hazard ratio (HR) 3.7; 95% confidence interval (CI) 1.3-10.9] and HER2-enriched (HR 4.4; 95% CI 1.5-12.8) subtypes compared with the luminal A subtype. Overall, 25% of the metastases were basal-like, 32% HER2-enriched, 10% luminal A, 28% luminal B, and 5% normal-like. We show that tumor characteristics and molecular subtypes of breast cancer metastases significantly influence post-relapse patient survival, emphasizing that molecular investigations at relapse provide prognostic and clinically relevant information.
  •  
8.
  •  
9.
  •  
10.
  • Azimi, A, et al. (författare)
  • Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
  • 2017
  • Ingår i: Cell death & disease. - : Springer Science and Business Media LLC. - 2041-4889. ; 8:8, s. e3029-
  • Tidskriftsartikel (refereegranskat)abstract
    • A majority of patients with BRAF-mutated metastatic melanoma respond to therapy with BRAF inhibitors (BRAFi), but relapses are common owing to acquired resistance. To unravel BRAFi resistance mechanisms we have performed gene expression and mass spectrometry based proteome profiling of the sensitive parental A375 BRAF V600E-mutated human melanoma cell line and of daughter cell lines with induced BRAFi resistance. Increased expression of two novel resistance candidates, aminopeptidase-N (CD13/ANPEP) and ETS transcription factor FLI1 was observed in the BRAFi-resistant daughter cell lines. In addition, increased levels of the previously reported resistance mediators, receptor tyrosine kinase ephrine receptor A2 (EPHA2) and the hepatocyte growth factor receptor MET were also identified. The expression of these proteins was assessed in matched tumor samples from melanoma patients obtained before BRAFi and after disease progression. MET was overexpressed in all progression samples while the expression of the other candidates varied between the individual patients. Targeting CD13/ANPEP by a blocking antibody induced apoptosis in both parental A375- and BRAFi-resistant daughter cells as well as in melanoma cells with intrinsic BRAFi resistance and led to dephosphorylation of EPHA2 on S897, previously demonstrated to cause inhibition of the migratory capacity. AKT and RSK, both reported to induce EPHA2 S897 phosphorylation, were also dephosphorylated after inhibition of CD13/ANPEP. FLI1 silencing also caused decreases in EPHA2 S897 phosphorylation and in total MET protein expression. In addition, silencing of FLI1 sensitized the resistant cells to BRAFi. Furthermore, we show that BRAFi in combination with the multi kinase inhibitor dasatinib can abrogate BRAFi resistance and decrease both EPHA2 S897 phosphorylation and total FLI1 protein expression. This is the first report presenting CD13/ANPEP and FLI1 as important mediators of resistance to BRAF inhibition with potential as drug targets in BRAFi refractory melanoma.
  •  
11.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  • Perers, Bengt, et al. (författare)
  • Solceller 1996
  • 1996
  • Rapport (övrigt vetenskapligt/konstnärligt)
  •  
17.
  • Stenmark, Maj, et al. (författare)
  • From High-Level Task Descriptions to Executable Robot Code
  • 2015
  • Ingår i: Advances in Intelligent Systems and Computing. - Cham : Springer International Publishing. - 2194-5357. - 9783319113098 ; 323, s. 189-202
  • Konferensbidrag (refereegranskat)abstract
    • For robots to be productive co-workers in the manufacturing industry, it is necessary that their human colleagues can interact with them and instruct them in a simple manner. The goal of our research is to lower the threshold for humans to instruct manipulation tasks, especially sensorcontrolled assembly. In our previous work we have presented tools for high-level task instruction, while in this paper we present how these symbolic descriptions of object manipulation are translated into executable code for our hybrid industrial robot controllers.
  •  
18.
  •  
19.
  •  
20.
  • Abou-Ras, Daniel, et al. (författare)
  • Innovation highway : Breakthrough milestones and key developments in chalcopyrite photovoltaics from a retrospective viewpoint
  • 2017
  • Ingår i: Thin Solid Films. - : Elsevier BV. - 0040-6090 .- 1879-2731. ; 633, s. 2-12
  • Tidskriftsartikel (refereegranskat)abstract
    • The present contribution is a summary of an event that was organized as a special evening session in Symposium V "Chalcogenide Thin-Film Solar Cells" at the E-MRS 2016 Spring Meeting, Lille, France. The presentations in this session were given by the coauthors of this paper. These authors present retrospectives of key developments in the field of Cu(In,Ga)(S,Se)(2) solar cells as they themselves had witnessed in their laboratories or companies. Also, anecdotes are brought up, which captured interesting circumstances in that evolutionary phase of the field. Because the focus was on historical perspectives rather than a comprehensive review of the field, recent developments intentionally were not addressed.
  •  
21.
  • Bayrak Pehlivan, Ilknur, et al. (författare)
  • Scalable and thermally-integrated solar water-splitting modules using Ag-doped Cu(In,Ga)Se2 and NiFe layered double hydroxide nanocatalysts
  • 2022
  • Ingår i: Journal of Materials Chemistry A. - : Royal Society of Chemistry. - 2050-7488 .- 2050-7496. ; 10:22, s. 12079-12091
  • Tidskriftsartikel (refereegranskat)abstract
    • Photovoltaic (PV) electrolysis is an important and powerful technology for environmentally-friendly fuel production based on solar energy. By directly coupling solar cell materials to electrochemical systems to perform water electrolysis, solar energy can be converted into hydrogen fuel utilizing locally-generated heat and avoid losses from DC-DC convertors and power grid transmission. Although there have been significant contributions to the photoelectrochemical and PV-electrolysis field using isolated laboratory cells, the capacity to upscale and retain high levels of efficiency in larger modules remains a critical issue for widespread use and application. In this study, we develop thermally-integrated, solar-driven water-splitting device modules using AgCu(In,Ga)Se2 (ACIGS) and an alkaline electrolyzer system with NiFe-layered double hydroxide (LDH) nanocatalysts with devices of 82-100 cm2 area. The Ga-content in the ACIGS solar cells is tuned to achieve an optimal voltage for the catalyst system, and the average efficiencies and durability of the PV-electrolyzer were tested in up to seven-day indoor and 21 day outdoor operations. We achieved a solar-to-hydrogen (STH) module efficiency of 13.4% from gas volume measurements for the system with a six-cell CIGS-electrolyzer module with an active area of 82.3 cm2 and a 17.27% PV module efficiency under 100 mW cm−2 illumination, and thus 77% electricity-to-hydrogen efficiency at one full sun. Outdoor tests under mid-Europeen winter conditions exhibited an STH efficiency between 10 and 11% after the initial activation at the installation site in Jülich, Germany, in December 2020, despite challenging outdoor-test weather conditions, including sub-zero temperatures. 
  •  
22.
  •  
23.
  •  
24.
  • Edvardsson, Nils, 1942, et al. (författare)
  • Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry.
  • 2011
  • Ingår i: Europace. - : Oxford University Press (OUP). - 1532-2092 .- 1099-5129. ; 13:2, s. 262-269
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims To collect information on the use of the Reveal implantable loop recorder (ILR) in the patient care pathway and to investigate its effectiveness in the diagnosis of unexplained recurrent syncope in everyday clinical practice. Methods and results Prospective, multicentre, observational study conducted in 2006-2009 in 10 European countries and Israel. Eligible patients had recurrent unexplained syncope or pre-syncope. Subjects received a Reveal Plus, DX or XT. Follow up was until the first recurrence of a syncopal event leading to a diagnosis or for ≥1 year. In the course of the study, patients were evaluated by an average of three different specialists for management of their syncope and underwent a median of 13 tests (range 9-20). Significant physical trauma had been experienced in association with a syncopal episode by 36% of patients. Average follow-up time after ILR implant was 10 ± 6 months. Follow-up visit data were available for 570 subjects. The percentages of patients with recurrence of syncope were 19, 26, and 36% after 3, 6, and 12 months, respectively. Of 218 events within the study, ILR-guided diagnosis was obtained in 170 cases (78%), of which 128 (75%) were cardiac. Conclusion A large number of diagnostic tests were undertaken in patients with unexplained syncope without providing conclusive data. In contrast, the ILR revealed or contributed to establishing the mechanism of syncope in the vast majority of patients. The findings support the recommendation in current guidelines that an ILR should be implanted early rather than late in the evaluation of unexplained syncope.
  •  
25.
  •  
26.
  •  
27.
  •  
28.
  • HUDNER, J, et al. (författare)
  • PREPARATION OF YBA2CU3O7-X FILMS AND YBA2CU3O7-X/Y2O3 MULTILAYERS USING COEVAPORATION AND ATOMIC OXYGEN
  • 1993
  • Ingår i: Journal of Applied Physics. - : AIP Publishing. - 0021-8979 .- 1089-7550. ; 73, s. 3096-3098
  • Tidskriftsartikel (refereegranskat)abstract
    • Thin layers of YBa2Cu3O7-x (YBCO) deposited on LaAlO3 substrates have been prepared in situ by coevaporation of Y, Ba, and Cu. Incorporation of oxygen was accomplished by an atomic oxygen beam source with high cracking efficiency. The total oxygen flow at the substrate could be kept low enough to permit the use of a quadrupole mass spectrometer for evaporation rate monitoring. Films were strongly c-axis oriented with rocking curve full width at half-maximum values of 0.6-degrees. Transport measurements on patterned films yielded critical current densities of 6 x 10(6) A/cm2 at 77 K. The deposition method was demonstrated to be feasible for preparation of Y2O3/YBCO heterostructures.
  •  
29.
  •  
30.
  •  
31.
  •  
32.
  •  
33.
  •  
34.
  •  
35.
  •  
36.
  •  
37.
  •  
38.
  • Kylner, Angela, et al. (författare)
  • Impurities in chemical bath deposited CdS films for Cu(In,Ga)Se-2 solar cells and their stability
  • 1996
  • Ingår i: JOURNAL OF THE ELECTROCHEMICAL SOCIETY. - 0013-4651. ; 143:8, s. 2662-2669
  • Tidskriftsartikel (refereegranskat)abstract
    • The highest efficiencies for Cu(In,Ga)Se-2-based thin dim solar cells have been achieved with CdS films prepared by a solution growth method known as the chemical bath deposition (CBD) technique. The impurity content in such cadmium sulfide films has bee
  •  
39.
  •  
40.
  •  
41.
  •  
42.
  •  
43.
  •  
44.
  •  
45.
  • Schneider, Sebastian, et al. (författare)
  • Simple method for optimization of classical electron magnetic circular dichroism measurements : The role of structure factor and extinction distances
  • 2018
  • Ingår i: Physical Review Materials. - : AMER PHYSICAL SOC. - 2475-9953. ; 2:11
  • Tidskriftsartikel (refereegranskat)abstract
    • Electron magnetic circular dichroism (EMCD), the electron wave analog of x-ray magnetic circular dichroism (XMCD), allows for the element specific measurement of the spin and orbital magnetic moments with up to nanometer resolution. However, due to dynamical diffraction effects, the signal-to-noise ratios of EMCD spectra are often very low. We describe a simple set of rules, how to set up a geometry for a classical EMCD experiment on an arbitrary crystal structure to get a maximum dichroic signal. The procedure is based on an evaluation of the structure factor and extinction distances. Proof-of-concept simulations and experiments on a FeGe crystal present a successful test of these guidelines.
  •  
46.
  •  
47.
  •  
48.
  • Sterner, Jan, et al. (författare)
  • Sulfurization of thin film solar cell absorbers
  • 2000
  • Ingår i: Sixteent h European Photovoltaic Solar Energy Conference and Exhibition, Glasgow, May 1-5. ; , s. 771-774
  • Konferensbidrag (refereegranskat)
  •  
49.
  •  
50.
  • Stolt, Ragnar, et al. (författare)
  • Second-Order Peak Detection for Multicomponent High-Resolution LC/MS Data
  • 2006
  • Ingår i: Analytical Chemistry. - : American Chemical Society (ACS). - 0003-2700 .- 1520-6882. ; 78:4, s. 975-83
  • Tidskriftsartikel (refereegranskat)abstract
    • The first step when analyzing multicomponent LC/MS data from complex samples such as biofluid metabolic profiles is to separate the data into information and noise via, for example, peak detection. Due to the complex nature of this type of data, with problems such as alternating backgrounds and differing peak shapes, this can be a very complex task. This paper presents and evaluates a two-dimensional peak detection algorithm based on raw vector-represented LC/MS data. The algorithm exploits the fact that in high-resolution centroid data chromatographic peaks emerge flanked with data voids in the corresponding mass axis. According to the proposed method, only 4‰ of the total amount of data from a urine sample is defined as chromatographic peaks; however, 94% of the raw data variance is captured within these peaks. Compared to bucketed data, results show that essentially the same features that an experienced analyst would define as peaks can automatically be extracted with a minimum of noise and background. The method is simple and requires a priori knowledge of only the minimum chromatographic peak widtha system-dependent parameter that is easily assessed. Additional meta parameters are estimated from the data themselves. The result is well-defined chromatographic peaks that are consistently arranged in a matrix at their corresponding m/z values. In the context of automated analysis, the method thus provides an alternative to the traditional approach of bucketing the data followed by denoising and/or one-dimensional peak detection. The software implementation of the proposed algorithm is available at http://www.anchem.su.se/peakd as compiled code for Matlab.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-50 av 59
Typ av publikation
tidskriftsartikel (34)
konferensbidrag (20)
rapport (4)
patent (1)
Typ av innehåll
refereegranskat (44)
övrigt vetenskapligt/konstnärligt (14)
populärvet., debatt m.m. (1)
Författare/redaktör
Stolt, Lars (15)
Stolt, MF (11)
Hansson, J. (10)
Stolt, L. (10)
Kessler, John (9)
Brage, SE (7)
visa fler...
Bodegård, Marika (7)
Azimi, A (6)
Egyhazi, S (5)
Rönnelid, Mats (5)
Johansson, CH (5)
Bergh, J (4)
Karlsson, B (4)
Nordblad, P (4)
Tuominen, R (4)
Ohlsén, H (4)
Johansson, H (3)
Hatschek, T (3)
Wennerberg, Johan (3)
Andersson, M (3)
LILIEMARK, J (3)
Lundberg, Olle (3)
Lehtio, J (3)
Sjövall, K (3)
Pernemalm, M (3)
Einbeigi, Z (3)
Gustafsson, L (2)
KLARESKOG, L (2)
Lu, Jun (2)
Berg, Agneta (2)
Carlsson, L. (2)
Lundeberg, Joakim (2)
Padyukov, L (2)
Alfredsson, L (2)
Franck, J (2)
Ronnelid, J (2)
Olsson, E (2)
GRUBER, A (2)
Linderholm, B (2)
Borg, S. (2)
Thomas, O (2)
Malmberg, M (2)
Balldin, J (2)
Halldin, J (2)
Stolt, G (2)
Willander, A (2)
Stolt, P (2)
Zhou, R (2)
Loman, N. (2)
Granath, Karin (2)
visa färre...
Lärosäte
Uppsala universitet (24)
Karolinska Institutet (22)
Kungliga Tekniska Högskolan (5)
Högskolan Dalarna (5)
Lunds universitet (4)
Göteborgs universitet (3)
visa fler...
Högskolan Kristianstad (3)
Linköpings universitet (3)
Stockholms universitet (1)
Högskolan Väst (1)
RISE (1)
visa färre...
Språk
Engelska (55)
Svenska (4)
Forskningsämne (UKÄ/SCB)
Teknik (18)
Naturvetenskap (9)
Medicin och hälsovetenskap (8)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy